American Oriental Bioengineering
(OTC) AOBI
American Oriental Bioengineering Financials at a Glance
Market Cap
$100
Revenue (TTM)
$121.58M
Net Income (TTM)
$91.02M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1039.81 (High)
Dividend
$0.00
Beta (Volatility)
1039.81 (High)
Price
$0.00
Volume
10
Open
$0.00
Price
$0.00
Volume
10
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
1039.81 (High)
Price
$0.00
Volume
10
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
AOBI News
Wall Street's Best Hidden Stocks
3 Top Stocks at Half-Price
7 Reasons to Worry About Next Week
The 5 Cheapest Stocks Right Now
3 Top Stocks at Half-Price
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout American Oriental Bioengineering
AOBI Financials
Key Financial Metrics (TTM)
Gross Margin
31%
Operating Margin
-38%
Net Income Margin
-41%
Return on Equity
0%
Return on Capital
-16%
Return on Assets
-13%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.00
Shares Outstanding
73.00K
Volume
10
Avg. Volume
0.902
Financials (TTM)
Gross Profit
$44.36M
Operating Income
$54.97M
EBITDA
$39.64M
Operating Cash Flow
$46.45M
Capital Expenditure
$26.14M
Free Cash Flow
$72.60M
Cash & ST Invst.
$7.10M
Total Debt
$67.64M
American Oriental Bioengineering Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$17.94M
-39.2%
Gross Profit
$3.11M
-51.9%
Gross Margin
17.33%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$0.03
N/A
Employees
3,719
N/A
Net Income
$21.18M
-210.8%
EBITDA
$16.01M
+2.6%
Quarterly Fundamentals
Net Cash
$89.54M
-119.6%
Accounts Receivable
$27.25M
-40.6%
Inventory
$20.52M
-25.5%
Long Term Debt
$5.06M
+786.0%
Short Term Debt
$87.71M
+31.6%
Return on Assets
-13.38%
N/A
Return on Invested Capital
-16.16%
N/A
Free Cash Flow
$30.80M
-647.0%
Operating Cash Flow
$17.05M
-531.1%